Do we need a third dose of @pfizer #vaccine? I spoke with @ShyannMalone about the data (and lack thereof). Key point to remember: antibodies are *supposed* to decline with time. Not a compelling indication for booster. Show us B/T cell data please.
Not enough time to discuss "why not?" - as vaccines are safe, effective, and plentiful. They are definitely NOT plentiful outside of the US - extra stockpiles could potentially be shared to reduce cases elsewhere (and the variants that arise from them).
Data stronger to consider third dose in immunosuppressed patients. Reasonable given the small population size, outsized benefit.
We'll see what data @pfizer is sitting on. Important to be skeptical (since boosters will pad Pharma bottom line) but not cynical. Despite the profit motive, boosters may be the right choice if the data directs us that way.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
